seed
Stage
1
Investors
About
Xenome is a privately held biopharmaceutical company developing a novel therapeutic product for the management of moderate to severe pain, headquartered in Brisbane with offices in San Diego, California.
Explore Xenome's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.